TerminatedNot Applicable

A Study of a Mastoid Device in Subjects With Ménière's Disease

Stopped: Slow accrual

United States7 participantsStarted 2019-01-29

Plain-language summary

The purpose of this study is to investigate the efficacy of a mastoid treatment device in patients with active Ménière's disease that is not controlled by traditional medical management

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults aged 18 and older
✓. Clinical diagnosis of Ménière's disease, with classical symptoms:

Exclusion criteria

✕. Atypical medical history of Ménière's symptoms and questionable Ménière's diagnosis
✕. Bilateral Ménière's disease

What they're measuring

Change in the Number of Monthly Vertigo Episodes

Timeframe: Baseline to 90 days

Trial details

NCT IDNCT03520322

SponsorUniversity of Rochester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02-14

Results submitted2024-11-04

View on ClinicalTrials.gov More Meniere Disease trials